Stay updated on Carboplatin/Etoposide +/- Atezolizumab & Trilaciclib Clinical Trial

Sign up to get notified when there's something new on the Carboplatin/Etoposide +/- Atezolizumab & Trilaciclib Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Carboplatin/Etoposide +/- Atezolizumab & Trilaciclib Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The site footer’s revision label changed from v3.8.0 to v3.8.1.
    Difference
    0.1%
    Check dated 2026-11-21T11:42:16.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    16 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The site footer revision changed from v3.7.2 to v3.8.0.
    Difference
    0.1%
    Check dated 2026-10-31T11:58:00.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    A notice announces NIH website transition updates and says the term “Super Intelligence” may appear in place of “Artificial Intelligence” during the transition.
    Difference
    0.5%
    Check dated 2026-10-24T11:33:23.000Z thumbnail image
  6. Check
    36 days ago
    Change Detected
    Summary
    The site revision identifier changed from v3.7.1 to v3.7.2.
    Difference
    0.1%
    Check dated 2026-10-17T13:02:40.000Z thumbnail image
  7. Check
    43 days ago
    Change Detected
    Summary
    The footer now displays site revision v3.7.1 instead of v3.7.0.
    Difference
    0.1%
    Check dated 2026-10-10T12:29:38.000Z thumbnail image
  8. Check
    64 days ago
    Change Detected
    Summary
    A new revision entry v3.7.0 was added to the study's history, and the previous revision v3.6.6 was removed from the list.
    Difference
    0.1%
    Check dated 2026-09-19T20:34:00.000Z thumbnail image

Stay in the know with updates to Carboplatin/Etoposide +/- Atezolizumab & Trilaciclib Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Carboplatin/Etoposide +/- Atezolizumab & Trilaciclib Clinical Trial page.